Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Baratta

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Hepatology (Baltimore, Md.)|December 7, 2019
Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLDGuido Carpino, Maria Del Ben, Daniele Pastori, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 16, 2023
PAD4-Induced NETosis Via Cathepsin G-Mediated Platelet-Neutrophil Interaction in ChAdOx1 Vaccine-Induced Thrombosis-Brief ReportRoberto Carnevale, Martina Leopizzi, Marcello Dominici, et al.
Thrombosis Research|November 22, 2025
Platelet Thromboxane B<sub>2</sub> overproduction associated with liver fibrosis severity in patients with MASLDFrancesco Baratta, Nicholas Cocomello, Guido Carpino, et al.
Scientific Reports|March 1, 2018
Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing StrategyAlessia Di Costanzo, Francesca Belardinilli, Diego Bailetti, et al.
Antioxidants (Basel, Switzerland)|October 27, 2022
The Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors Reduce Platelet Activation and Thrombus Formation by Lowering NOX2-Related Oxidative Stress: A Pilot StudyPasquale Pignatelli, Francesco Baratta, Raffaella Buzzetti, et al.
International Journal of Molecular Sciences|July 12, 2025
Oxidative Stress and Low-Grade Endotoxemia in Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) and Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS): Insights from a Cross-Sectional StudyChiara Maria Totè, Martina Capponi, Francesca Salvatori, et al.
International Journal of Molecular Sciences|July 20, 2021
Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL PathwaysVittoria Cammisotto, Francesco Baratta, Valentina Castellani, et al.
Atherosclerosis|December 29, 2016
Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storageAlessia Di Costanzo, Laura D'Erasmo, Licia Polimeni, et al.
Clinical and Translational Gastroenterology|May 29, 2020
Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver DiseaseFlaminia Ferri, Monica Mischitelli, Giulia Tozzi, et al.
Atherosclerosis|April 12, 2017
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort studyFrancesco Angelico, Stefano Ginanni Corradini, Daniele Pastori, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Hepatology (Baltimore, Md.)|December 7, 2019
Increased Liver Localization of Lipopolysaccharides in Human and Experimental NAFLDGuido Carpino, Maria Del Ben, Daniele Pastori, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 16, 2023
PAD4-Induced NETosis Via Cathepsin G-Mediated Platelet-Neutrophil Interaction in ChAdOx1 Vaccine-Induced Thrombosis-Brief ReportRoberto Carnevale, Martina Leopizzi, Marcello Dominici, et al.
Thrombosis Research|November 22, 2025
Platelet Thromboxane B<sub>2</sub> overproduction associated with liver fibrosis severity in patients with MASLDFrancesco Baratta, Nicholas Cocomello, Guido Carpino, et al.
Scientific Reports|March 1, 2018
Evaluation of Polygenic Determinants of Non-Alcoholic Fatty Liver Disease (NAFLD) By a Candidate Genes Resequencing StrategyAlessia Di Costanzo, Francesca Belardinilli, Diego Bailetti, et al.
Antioxidants (Basel, Switzerland)|October 27, 2022
The Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors Reduce Platelet Activation and Thrombus Formation by Lowering NOX2-Related Oxidative Stress: A Pilot StudyPasquale Pignatelli, Francesco Baratta, Raffaella Buzzetti, et al.
International Journal of Molecular Sciences|July 12, 2025
Oxidative Stress and Low-Grade Endotoxemia in Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS) and Paediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS): Insights from a Cross-Sectional StudyChiara Maria Totè, Martina Capponi, Francesca Salvatori, et al.
International Journal of Molecular Sciences|July 20, 2021
Proprotein Convertase Subtilisin Kexin Type 9 Inhibitors Reduce Platelet Activation Modulating ox-LDL PathwaysVittoria Cammisotto, Francesco Baratta, Valentina Castellani, et al.
Atherosclerosis|December 29, 2016
Non-alcoholic fatty liver disease and subclinical atherosclerosis: A comparison of metabolically- versus genetically-driven excess fat hepatic storageAlessia Di Costanzo, Laura D'Erasmo, Licia Polimeni, et al.
Clinical and Translational Gastroenterology|May 29, 2020
Reduced Lysosomal Acid Lipase Activity in Blood and Platelets Is Associated With Nonalcoholic Fatty Liver DiseaseFlaminia Ferri, Monica Mischitelli, Giulia Tozzi, et al.
Atherosclerosis|April 12, 2017
Severe reduction of blood lysosomal acid lipase activity in cryptogenic cirrhosis: A nationwide multicentre cohort studyFrancesco Angelico, Stefano Ginanni Corradini, Daniele Pastori, et al.
Pageof 9